Mary Eapen MD
Associate Professor, Medicine, Medical College of Wisconsin
Join to View Full Profile
9000 W Wisconsin AveDivision Of Pediatric Hematology/OncologyMilwaukee, WI 53226
Phone+1 414-456-4170
Fax+1 414-456-6543
Are you Dr. Eapen?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Mary Eapen, MD is a pediatric hematologist/oncologist in Milwaukee, Wisconsin. She is currently licensed to practice medicine in Wisconsin and Minnesota. She is an Associate Professor at Medical College of Wisconsin.
Education & Training
University of MinnesotaFellowship, Pediatric Hematology/Oncology, 1997 - 2000- University of MinnesotaResidency, Pediatrics, 1995 - 1997
Ahmadu Bello UniversityClass of 1986
Certifications & Licensure
WI State Medical License 2000 - 2025
MN State Medical License 1998 - 2020
American Board of Pediatrics Pediatric Hematology-Oncology
Publications & Presentations
PubMed
- Hematopoietic cell transplant compared with standard care in adolescents and young adults with sickle cell disease.Mark C Walters, Mary Eapen, Yiwen Liu, Fuad El Rassi, Edmund K Waller
Blood Advances. 2025-03-11 - Haploidentical Bone Marrow Transplantation for Sickle Cell Disease.Adetola A Kassim, Mark C Walters, Mary Eapen, Madoc Smith, Brent R Logan
NEJM Evidence. 2025-03-01 - 1 citationsPlatelet-Targeted Gene Therapy for Hemophilia A with Inhibitor History.Mary Eapen, Lynn M Malec, Myriam A Armant, Bryon D Johnson, Qizhen Shi
The New England Journal of Medicine. 2025-01-23
Press Mentions
Researchers Develop a Validated Pediatric Disease Risk Index for AML and ALLFebruary 1st, 2021- Navigating Treatment Options and Communication in Relapsed Pediatric AMLJune 17th, 2024
Grant Support
- Medical College of Wisconsin Physician Scientist Immersion ProgramMEDICAL COLLEGE OF WISCONSIN2023–2028
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- Cure Sickle CellMEDICAL COLLEGE OF WISCONSIN2018–2026
- A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory AntibodiesMEDICAL COLLEGE OF WISCONSIN2019–2025
- A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory AntibodiesMEDICAL COLLEGE OF WISCONSIN2019–2025
- A Phase I Clinical Trial Testing Feasibility of Hematopoietic Stem Cell Gene Therapy Using Platelet Factor VIII to Safely Improve Hemostasis for Severe Hemophilia A with Inhibitory AntibodiesMEDICAL COLLEGE OF WISCONSIN2019–2025
